Keywords: مهار کننده های فسفودی استراز; Cardiovascular System; Phosphodiesterase Inhibitors; Erectile Dysfunction; Safety;
مقالات ISI مهار کننده های فسفودی استراز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های فسفودی استراز; Sexual dysfunction; Erectile dysfunction; Phosphodiesterase inhibitors; Penile prosthesis;
Keywords: مهار کننده های فسفودی استراز; Aspirin; Phosphodiesterase inhibitors; Glycoprotein IIb-IIIa inhibitors; Thrombosis; Shear stress; Mechanical circulatory support;
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase inhibitors; Alzheimer's disease; Memory; Transgenic models; Cyclic nucleotides;
Keywords: مهار کننده های فسفودی استراز; Pyridazinone; Phosphodiesterase inhibitors; Anti-inflammatory; PDE4;
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase; Phosphodiesterase inhibitors; cAMP; cGMP; Cancer;
Keywords: مهار کننده های فسفودی استراز; AC; adenylate cyclase; ADHD; attention deficit hyperactivity disorder; ACC; anterior cingulate cortex; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BBB; blood-brain barrier;
Keywords: مهار کننده های فسفودی استراز; Sonic hedgehog; Nasal mucus; Smell; Olfaction; Hyposmia; Theophylline; Phosphodiesterase inhibitors;
Keywords: مهار کننده های فسفودی استراز; ActRIIB; activin receptor IIB; IGF-1; insulin-like growth factor; IL-6; interleukin; PDE; phosphodiesterase inhibitors; GDF-8; growth differentiation factor 8; TNF-α; tumor necrosis factor alpha; QCT; quantitative computed tomography; FoxO; forkhead box;
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase; Cardiovascular disease; Potential therapeutic; Phosphodiesterase inhibitors;
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase inhibitors; Viagra; Erectile dysfunction; Prostate cancer; Recurrence;
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase Inhibitors; Cavernous Nerve Injury; Iatrogenic Erectile Dysfunction; Penile Rehabilitation; Radical Prostatectomy;
Keywords: مهار کننده های فسفودی استراز; Acetylcholinesterase; Alternative treatment; Balloon angioplasty; Dysautonomia; Mediterranean diet; Immunomodulation; Neurodegeneration; Pharmacological intervention; Phosphodiesterase inhibitors; Dietary supplements; Surgical intervention; Cardiovascular
Keywords: مهار کننده های فسفودی استراز; Liquid chromatography-mass spectrometry; Drugs in sport; Azole antifungals; Benzodiazepines; Phosphodiesterase inhibitors; Selective serotonin reuptake inhibitors;
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase inhibitors; Memory; Synaptic plasticity;
Keywords: مهار کننده های فسفودی استراز; α1-Adrecoceptor antagonists; β3-adrenoceptor agonists; incontinence; phosphodiesterase inhibitors; urgency
Keywords: مهار کننده های فسفودی استراز; Multiple sclerosis; Erectile dysfunction; Ejaculation dysfunction; Phosphodiesterase inhibitors; Intracavernous injections; Penile vibratory stimulation; Midodrine; Sclérose en plaques; Dysfonction érectile; Dysfonction éjaculatoire; Inhibiteurs de la
Keywords: مهار کننده های فسفودی استراز; Alzheimer's disease; Phosphodiesterase inhibitors; Aβ degradation; Cognition; Astrocytes; Transgenic mice;
Uso continuado de inhibidores de la PDE5 en el tratamiento de la disfunción eréctil: nuevas perspectivas y oportunidades
Keywords: مهار کننده های فسفودی استراز; Disfunción eréctil; Inhibidores de la fosfodiesterasa; Inhibidores de la PDE5; Erectile dysfunction; Phosphodiesterase inhibitors; PDE5 inhibitors;
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil
Keywords: مهار کننده های فسفودی استراز; Avanafil; Erectile Dysfunction; Survey; Phosphodiesterase Inhibitors;
The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers
Keywords: مهار کننده های فسفودی استراز; Phase I; Healthy volunteers; Pharmacokinetics; Phosphodiesterase inhibitors; Safety;
Effect of co-administration of two different phosphodiesterase inhibitors and a β3-adrenoceptor agonist in an experimental model of detrusor overactivity
Keywords: مهار کننده های فسفودی استراز; Overactive urinary bladder; Phosphodiesterase inhibitors; Adrenergic beta-3 receptor agonists;
Antimuscarinics, β-3 Agonists, and Phosphodiesterase Inhibitors in the Treatment of Male Lower Urinary Tract Symptoms
Keywords: مهار کننده های فسفودی استراز; Lower urinary tract symptoms; Storage LUTS; Phosphodiesterase inhibitors; Antimuscarinics; β-3 Agonists;
Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes
Keywords: مهار کننده های فسفودی استراز; Drug delivery; Liposomes; Erythrocytes; Diabetes; Phosphodiesterase inhibitors
Effets indésirables oculaires des traitements systémiques : une mise à jour
Keywords: مهار کننده های فسفودی استراز; Effets indésirables oculaires; Thérapies ciblées anticancéreuses; Interféron; Ãtanercept; Fingolimod; Biphosphonate; Inhibiteurs de la phosphodiestérase; Topiramate; Nicorandil; Ocular adverse effects; Cancer target therapy; Fingolimod; Etanercept;
The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase inhibitors; Schizophrenia; Immediate early genes; Haloperidol; Catalepsy;
Phosphodiesterase4D (PDE4D) - A risk factor for atrial fibrillation and stroke?
Keywords: مهار کننده های فسفودی استراز; PDE4D; Atrial fibrillation; Phosphodiesterase inhibitors; Cerebrovascular disease; Gene;
Distribution and function of 3â²,5â²-Cyclic-AMP phosphodiesterases in the human ovary
Keywords: مهار کننده های فسفودی استراز; 3â²,5â²-Cyclic-AMP phosphodiesterases; cAMP signalling; Ovary; Phosphodiesterase inhibitors;
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Keywords: مهار کننده های فسفودی استراز; Multidrug resistance; ABC transporters; Modulators; Tyrosine kinase inhibitors; Phosphodiesterase inhibitors; Marine sponges; Natural products
Repurposing human PDE4 inhibitors for neglected tropical diseases: Design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors
Keywords: مهار کننده های فسفودی استراز; Antiprotozoal agents; Cilomilast; Phosphodiesterase inhibitors; TbrPDEB1 Trypanosoma brucei;
Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase inhibitors; GEBR-7b; APP/PS1; Cognition; BDNF; CREB; Aβ; amyloid-β; AD; Alzheimer's disease; ANOVA; analysis of variance; BDNF; brain-derived neurotrophic factor; cAMP; cyclic adenosine monophosphate; CREB; cAMP response element-bindin
Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders
Keywords: مهار کننده های فسفودی استراز; Cyclic nucleotides; Dyskinesia's; Huntington's disease; Movement disorders; Parkinson's disease; Phosphodiesterase inhibitors;
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: مهار کننده های فسفودی استراز; prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Phosphodiesterase Type 5 Inhibitors and sudden sensorineural hearing loss
Keywords: مهار کننده های فسفودی استراز; phosphodiesterase inhibitors; sudden hearing loss; tinnitus
Hipertensión arterial pulmonar
Keywords: مهار کننده های فسفودی استراز; Hipertensión pulmonar; Diagnóstico; Cateterismo derecho; Tratamiento; Inhibidores de la fosfodiesterasa; Antagonistas del receptor de endotelinaPulmonary hypertension; Diagnosis; Right catheterization; Treatment; Phosphodiesterase inhibitors; Endotelin-re
The Global Online Sexuality Survey (GOSS): The United States of America in 2011 Chapter II: Phosphodiesterase Inhibitors Utilization among English Speakers
Keywords: مهار کننده های فسفودی استراز; Survey; United States of America; Erectile Dysfunction; Phosphodiesterase Inhibitors; Treatment
Community Pharmacy Detection of Erectile Dysfunction in Men with Risk Factors or Who Seek Treatment or Advice but Lack a Valid Prescription
Keywords: مهار کننده های فسفودی استراز; Community Pharmacy Services; Erectile Dysfunction; Patient Education as Topic; Patient Education Handout; Referral and Consultation; Phosphodiesterase Inhibitors; Sildenafil; Tadalafil; Vardenafil; Prescription
Impact of a First Treatment with Phosphodiesterase Inhibitors on Men and Partners’ Quality of Sexual Life: Results of a Prospective Study in Primary Care
Keywords: مهار کننده های فسفودی استراز; Erectile Dysfunction; Self Esteem; Primary Care; Quality of Sexual Life; Phosphodiesterase Inhibitors; Couple Sexual Health
SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction
Keywords: مهار کننده های فسفودی استراز; Erectile Dysfunction; Oral Drug Treatment; Phosphodiesterase Inhibitors; Intracavernous Self-Injection Therapy; Transurethral Alprostadil Therapy; Combination Therapies; Vacuum Device Therapy
Sildenafil Effect on the Human Bladder Involves the L-cysteine/Hydrogen Sulfide Pathway: A Novel Mechanism of Action of Phosphodiesterase Type 5 Inhibitors
Keywords: مهار کننده های فسفودی استراز; Human bladder; Lower urinary tract symptoms; Hydrogen sulfide; L-cysteine; Phosphodiesterase inhibitors; Sildenafil
Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies
Keywords: مهار کننده های فسفودی استراز; Diabetes; Erectile dysfunction; Endothelial dysfunction; Cardiovascular disease; Phosphodiesterase inhibitors; Intracavernous injection; Penile prosthesis; ReviewDiabète; Dysfonction érectile; Dysfonction endothéliale; Maladie cardiovasculaire; Inhibiteur
Thiophene inhibitors of PDE4: Crystal structures show a second binding mode at the catalytic domain of PDE4D2
Keywords: مهار کننده های فسفودی استراز; Phosphodiesterase inhibitors; PDE4; Thiophene; Crystallography; Gewald reaction
Current pharmacotherapy of lower urinary tract symptoms
Keywords: مهار کننده های فسفودی استراز; α1-adrecoceptor antagonists; β3-adrenoceptor agonists; incontinence; phosphodiesterase inhibitors; urgency
Evaluation and Management of the Adult Patient With Pulmonary Hypertension
Keywords: مهار کننده های فسفودی استراز; endothelin receptor antagonists; mean pulmonary artery pressure; phosphodiesterase inhibitors; prostanoids; pulmonary hypertension; right heart catheterization
Phosphodiesterase Type 5 Inhibitors in the Management of Non-neurogenic Male Lower Urinary Tract Symptoms: Critical Analysis of Current Evidence
Keywords: مهار کننده های فسفودی استراز; Lower urinary tract symptoms; Benign prostatic hyperplasia; Bladder neck; PDE receptors; Phosphodiesterase inhibitors; Cavernous tissue; Erectile dysfunction; Sildenafil; Vardenafil; Tadalafil; Udenafil; Alfuzosin; Tamsulosin; UK-369003
Are Phosphodiesterase Type 5 Inhibitors Associated with VisionâThreatening Adverse Events? A Critical Analysis and Review of the Literature
Keywords: مهار کننده های فسفودی استراز; Sildenafil; Tadalafil; Vardenafil; Ocular Complications; Phosphodiesterase Inhibitors; Erectile Dysfunction; Viagra and Eye;
Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension
Keywords: مهار کننده های فسفودی استراز; pulmonary arterial hypertension; tadalafil; bosentan; phosphodiesterase inhibitors; concomitant therapy;
Pulmonary Hemodynamic Response to Acute Combination and Monotherapy With Sildenafil and Brain Natriuretic Peptide in Rats With Monocrotaline-Induced Pulmonary Hypertension
Keywords: مهار کننده های فسفودی استراز; Natriuretic peptides; Sildenafil; Phosphodiesterase inhibitors; Cyclic guanosine monophosphate; Pulmonary arterial hypertension;
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
Keywords: مهار کننده های فسفودی استراز; prostatic hyperplasia; phosphodiesterase inhibitors; urodynamics; urinary bladder neck obstruction; BOOI; bladder outlet obstruction index; BPH; benign prostatic hyperplasia; BPH-LUTS; LUTS secondary to clinical BPH; ED; erectile dysfunction; I-PSS; Inter
Case Study: Erectile Dysfunction Following Spinal Cord Injury (CME)
Keywords: مهار کننده های فسفودی استراز; Spinal Cord Injury; Erection Dysfunction; Sexual Function; Phosphodiesterase Inhibitors; PDE5i; Injections; Vacuum Device; Intraurethral Pellet; Topical Therapy; Penile Prosthesis;